Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Bupropion on Residual and Cognitive Symptoms in SSRI-Treated Depression
This study is currently recruiting participants.
Study NCT00125957 Information provided by Mclean Hospital
First Received: August 1, 2005 Last Updated: June 4, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Major Depressive Disorder
Unipolar Depression
Additional conditions recognized in this trial
Depressive Disorder
Depressive Disorder, Major
Neurobehavioral Manifestations
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Mclean Hospital
National Association for Research on Schizophrenia and Affective Disorders.
Back to top of Main Content
